Diferencia entre revisiones de «Urinary alkalinization»

(Text replacement - "OR" to "'''OR'''")
Sin resumen de edición
 
Línea 5: Línea 5:
*[[Salicylate overdose]]
*[[Salicylate overdose]]
**Recommended for salicylate levels >30mg/dl
**Recommended for salicylate levels >30mg/dl
*Phenobarbital overdose (multidose activated charcoal is superior)
*[[Phenobarbital]] overdose (multidose activated charcoal is superior)
*Controversial:
*Controversial:
**[[Rhabdomyolysis]]
**[[Rhabdomyolysis]]
Línea 11: Línea 11:
==Contraindications==
==Contraindications==
#Patient unable to tolerate volume/sodium load
#Patient unable to tolerate volume/sodium load
#Hypokalemia
#[[Hypokalemia]]
#Renal insufficiency
#Renal insufficiency


Línea 31: Línea 31:


[[Category:Procedures]]
[[Category:Procedures]]
[[Category:Toxicology]]
[[Category:Renal]]

Revisión actual - 15:56 10 oct 2019

Background

  • Bicarb raises urinary pH which converts weak acids to their ionized form ("ion trap")

Indications

Contraindications

  1. Patient unable to tolerate volume/sodium load
  2. Hypokalemia
  3. Renal insufficiency

Procedure

  1. Give NaHCO3 1-2 mEq/kg IV bolus OR 3-4 mEq/kg IV infusion over 1hr
  2. Monitor urinary pH q15-30min until pH is 7.5-8.5
  3. Sustain alkalinization by either intermittent bolus or continuous bicarbonate infusion
  4. Monitor serum pH (do not allow to rise above 7.5-7.55)
  5. Monitor potassium (correct hypokalemia so that alkalinization can continue)

Complications

  1. Volume overload
  2. pH shifts
  3. Hypokalemia

References